Pleural Mesothelioma

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Evaluation of Skin Tests in Biotherapy Allergies

From Presentation to Diagnosis: Patterns of Pleural Effusion

INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)

DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma

Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study)

A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202)

TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

A Beta-only IL-2 ImmunoTherapY Study

The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma

Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma

TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO

A Study of MT027 in Patients with Pleural Malignant Tumors

A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma

Evaluation of Response by FLT PET in Mesothelioma

Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma

eRAPID: Online Symptom Reporting in Lung Cancer